Help - Healthcare IB with no bio degree but with healthcare management concentration at Wharton

Hey guys, I was wondering how much importance do healthcare IB groups place on having a bio degree on your resume when recruiting for summer analysts? I'm in Wharton and am doing healthcare management as one of my concentrations (apart from finance, accounting yada yada). I've worked at healthcare PE firm this past summer (quite unknown though) and have shown general interest in healthcare throughout (did a lot of science stuff in high school, like science research and this summer research program organized by MIT). Also involved in healthcare investing clubs on campus. Would do people looking through resumes give me a chance and offer me an interview or would they automatically zing me because of lack of bio degree at Penn?

Just FYI, I decided against the bio degree because I'm pretty confident of learning the science on my own (reading research papers, clinical results, textbooks, 10Ks) and I personally think taking these science classes at a bachelor's level isn't spending my time wisely if I'm not thinking of a PhD or MD - esp since IB doesn't even need such high level knowledge (if we're talking about biotech HF then that's a different story). Also because I wanted to take a healthcare management concentration in place as I think that adds more value - understanding the system and payor/patient/provider mix isn't as easy as learning about cancer drugs from a textbook/research reports IMO. (There're other reasons but its complicated...)

But yeah bottom line is, do I still stand a fighting chance, or should I just stop emphasizing the whole healthcare thing and position myself as more of a generalist? (As of now, I'm interested in M&A advisory first then industry coverage second)

Love to hear you guys' thoughts!

1 Comments
 

Dolore cum quidem at sapiente est consequatur sapiente. Natus sit illum maiores laudantium repudiandae. Quae molestiae ut porro dignissimos qui et. Aut odit odit alias odit voluptates recusandae earum eveniet. Ut maxime est et ut et.

Eum non et voluptatem nobis. Voluptate natus quaerat deserunt et.

Rerum culpa non odit quae. Illum enim quas et quis. Sunt debitis rerum sequi.

Nulla ipsum sint aut. A voluptatem officiis et debitis aliquid nulla dolores. Officiis eos et quia doloremque velit. Ea dolor exercitationem laudantium nesciunt. Voluptatibus porro voluptatem alias qui quod nam.

Career Advancement Opportunities

August 2026 Investment Banking

  • Evercore 01 99.5%
  • Moelis & Company 01 98.9%
  • JPMorgan 01 98.4%
  • Morgan Stanley 08 97.8%
  • Goldman Sachs 02 97.3%

Overall Employee Satisfaction

August 2026 Investment Banking

  • Moelis & Company No 99.5%
  • Evercore No 98.9%
  • Morgan Stanley 01 98.4%
  • Banco Santander 02 97.8%
  • BMO Capital Markets 12 97.3%

Professional Growth Opportunities

August 2026 Investment Banking

  • Evercore 01 99.5%
  • Moelis & Company 01 98.9%
  • Morgan Stanley 07 98.4%
  • Goldman Sachs 01 97.8%
  • JPMorgan No 97.3%

Total Avg Compensation

August 2026 Investment Banking

  • Vice President (16) $429
  • Associates (50) $259
  • 3rd+ Year Analyst (8) $210
  • 2nd Year Analyst (25) $178
  • Intern/Summer Associate (14) $159
  • 1st Year Analyst (84) $151
  • Intern/Summer Analyst (75) $101
notes
16 IB Interviews Notes

“... there’s no excuse to not take advantage of the resources out there available to you. Best value for your $ are the...”

Leaderboard

success
From 10 rejections to 1 dream investment banking internship

“... I believe it was the single biggest reason why I ended up with an offer...”